Amundi grew its holdings in Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) by 7.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 408,505 shares of the company's stock after buying an additional 29,189 shares during the quarter. Amundi owned about 0.17% of Celsius worth $11,851,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of the business. HM Payson & Co. lifted its holdings in shares of Celsius by 122.2% in the 4th quarter. HM Payson & Co. now owns 1,000 shares of the company's stock valued at $26,000 after buying an additional 550 shares during the period. River Global Investors LLP purchased a new position in Celsius in the 4th quarter valued at approximately $1,168,000. Raymond James Financial Inc. purchased a new position in Celsius in the 4th quarter valued at approximately $61,160,000. Arizona State Retirement System increased its stake in Celsius by 1.3% in the 4th quarter. Arizona State Retirement System now owns 43,958 shares of the company's stock valued at $1,158,000 after purchasing an additional 553 shares in the last quarter. Finally, Proficio Capital Partners LLC purchased a new position in Celsius in the 4th quarter valued at approximately $406,000. 60.95% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several equities analysts recently weighed in on the company. Roth Mkm reaffirmed a "buy" rating and issued a $38.00 price objective on shares of Celsius in a research note on Friday, February 21st. Morgan Stanley reaffirmed an "equal weight" rating and issued a $42.00 price objective on shares of Celsius in a research note on Thursday, December 26th. B. Riley reissued a "buy" rating and set a $49.00 price target (up previously from $44.00) on shares of Celsius in a research report on Friday, February 21st. TD Cowen downgraded Celsius from a "buy" rating to a "hold" rating and dropped their price target for the stock from $40.00 to $29.00 in a research report on Wednesday, January 22nd. Finally, Piper Sandler dropped their price target on Celsius from $47.00 to $33.00 and set an "overweight" rating for the company in a research report on Thursday, January 23rd. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, Celsius has a consensus rating of "Moderate Buy" and an average price target of $47.78.
Get Our Latest Research Report on CELH
Insider Activity at Celsius
In related news, insider Paul H. Storey sold 10,188 shares of the business's stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $25.77, for a total value of $262,544.76. Following the completion of the sale, the insider now directly owns 45,297 shares of the company's stock, valued at $1,167,303.69. The trade was a 18.36 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Joyce Russell sold 4,000 shares of the company's stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $28.47, for a total value of $113,880.00. Following the transaction, the director now directly owns 19,106 shares of the company's stock, valued at $543,947.82. This trade represents a 17.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.20% of the stock is owned by corporate insiders.
Celsius Trading Up 1.5 %
Shares of CELH traded up $0.44 during midday trading on Tuesday, reaching $30.37. 12,059,751 shares of the company were exchanged, compared to its average volume of 7,203,081. Celsius Holdings, Inc. has a 1-year low of $21.10 and a 1-year high of $98.85. The company has a market cap of $7.14 billion, a price-to-earnings ratio of 69.02, a P/E/G ratio of 2.90 and a beta of 1.90. The stock has a 50-day moving average price of $25.86 and a 200-day moving average price of $28.82.
Celsius (NASDAQ:CELH - Get Free Report) last announced its earnings results on Thursday, February 20th. The company reported $0.14 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.11 by $0.03. Celsius had a return on equity of 51.89% and a net margin of 10.70%. The business had revenue of $332.20 million for the quarter, compared to analyst estimates of $326.07 million. Equities research analysts anticipate that Celsius Holdings, Inc. will post 0.89 earnings per share for the current year.
About Celsius
(
Free Report)
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
See Also

Before you consider Celsius, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celsius wasn't on the list.
While Celsius currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.